Tech Company Financing Transactions
Emisphere Technologies Funding Round
Emisphere Technologies closed a $35.2 million funding round on 5/15/2013. Backers included private investors.
Transaction Overview
Company Name
Announced On
5/15/2013
Transaction Type
Debt
Amount
$35,168,880
Round
Undisclosed
Investors
Proceeds Purpose
The amount equals the aggregate principal amount of convertible notes evidencing restructured debt of the issuer. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
240 Cedar Knolls Road 103
Roseland, NJ 07927
USA
Roseland, NJ 07927
USA
Phone
Website
Email Address
Overview
Emisphere is charting new frontiers in drug delivery. The Company's core business strategy is to use its proprietary Eligen Technology to develop novel oral forms of injectable drugs or poorly absorbed compounds.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alan Rubino
Chief Financial Officer
Michael Garone
Chief Scientific Officer
Gary Riley
VP - Bus. Development
Carlos DeLecea
VP - Sales
Carl Sailer
Browse more venture capital transactions:
Prev: 5/15/2013: Skift venture capital transaction
Next: 5/15/2013: GCT Semiconductor venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs